Skip to main content

and
  1. Article

    Open Access

    Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis

    One target of rheumatoid arthritis (RA) treatment is to achieve early sustained remission; over the long term, patients in sustained remission have less structural joint damage and physical disability. We eval...

    Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk in Rheumatology and Therapy (2023)

  2. Article

    Open Access

    The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study

    AVERT-2 (a phase IIIb, two-stage study) evaluated abatacept + methotrexate versus methotrexate alone, in methotrexate-naive, anti-citrullinated protein antibody-positive patients with early (≤ 6 months), activ...

    Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk in Arthritis Research & Therapy (2023)

  3. Article

    Open Access

    Sudden Cardiac Arrest During a Sedated Cardiac Magnetic Resonance Study in a Nonsyndromic Child with Evolving Supravalvar Aortic Stenosis Due to Familial ELN Mutation

    Supravalvar aortic stenosis (SVAS) is a less common but clinically important form of left ventricular outflow tract obstruction, and commonly associated with Williams syndrome (WS). SVAS outside of WS may also...

    Dor Markush, Pedro A. Sanchez-Lara, Katheryn Grand, Robert Wong in Pediatric Cardiology (2023)

  4. No Access

    Article

    Randomized controlled trial investigating use of submucosal injection of EverLift™ in rates of complete resection of non-pedunculated 4–9 mm polyps

    Currently, cold snare polypectomy (CSP) without submucosal injection is recommended for removing polyps < 10 mm. Use of viscous submucosal agents has not been previously evaluated in CSP. We investigate the po...

    Mike T. Wei, Christine Y. Louie, Yu Chen in International Journal of Colorectal Disease (2022)

  5. No Access

    Article

    Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis

    Juvenile idiopathic arthritis (JIA) encompasses several forms of chronic inflammatory arthritis of unknown etiology presenting in children < 16 years of age, with a minimum symptom duration of 6 weeks. Approxi...

    Hermine I. Brunner, Robert Wong, Marleen Nys, Tzuyung D. Kou in Pediatric Drugs (2020)

  6. No Access

    Article

    Updated Assessment of Colorectal Cancer Incidence in the U.S. by Age, Sex, and Race/Ethnicity

    Whether recent updates to colon cancer screening guidelines benefit men and women or all race/ethnic groups equally is not clear.

    Ajay Ohri, Ann Robinson, Benny Liu, Taft Bhuket in Digestive Diseases and Sciences (2020)

  7. Article

    Open Access

    Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept

    Patients with polyarticular-course juvenile idiopathic arthritis (pJIA), receiving disease-modifying anti-rheumatic drugs with immunosuppressive effects, may be at increased risk of vaccine-preventable infecti...

    Hermine I. Brunner, Nikolay Tzaribachev, Gabriel Vega Cornejo in Pediatric Rheumatology (2020)

  8. No Access

    Article

    5-ASA Induced Recurrent Myopericarditis and Cardiac Tamponade in a Patient with Ulcerative Colitis

    Irene Sonu, Robert Wong, Michael E. Rothenberg in Digestive Diseases and Sciences (2013)

  9. Article

    Open Access

    Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis

    The purpose of this study was to investigate the effectiveness of adalimumab in enthesitis and peripheral arthritis in patients with ankylosing spondylitis (AS).

    Martin Rudwaleit, Pascal Claudepierre, Martina Kron in Arthritis Research & Therapy (2010)

  10. Article

    Open Access

    Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

    Ankylosing spondylitis (AS) is a chronic rheumatic disease associated with spinal inflammation that subsequently leads to progression of structural damage and loss of function. The fully human anti-tumor necro...

    Désirée van der Heijde, David Salonen, Barbara N Weissman in Arthritis Research & Therapy (2009)